Angiopep-2-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) polymersomes for dual-targeting drug delivery to glioma in rats

Fei Lu,1,2 Zhiyong Pang,2,3 Jingjing Zhao,2 Kai Jin,4 Haichun Li,2 Qiang Pang,2 Long Zhang,2 Zhiqing Pang2 1Department of Pharmacy, Xianju People’s Hospital, Xianju, Zhejiang, 2Department of Pharmaceutics, Key Laboratory of Smart Drug Delivery, Ministry of Education and PLA, School of Pha...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Lu F, Pang Z, Zhao J, Jin K, Li H, Pang Q, Zhang L
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://doaj.org/article/014376443db64db6a24101d330ab6563
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:014376443db64db6a24101d330ab6563
record_format dspace
spelling oai:doaj.org-article:014376443db64db6a24101d330ab65632021-12-02T07:37:00ZAngiopep-2-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) polymersomes for dual-targeting drug delivery to glioma in rats1178-2013https://doaj.org/article/014376443db64db6a24101d330ab65632017-03-01T00:00:00Zhttps://www.dovepress.com/angiopep-2-conjugated-polyethylene-glycol-co-polye-caprolactone-polyme-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Fei Lu,1,2 Zhiyong Pang,2,3 Jingjing Zhao,2 Kai Jin,4 Haichun Li,2 Qiang Pang,2 Long Zhang,2 Zhiqing Pang2 1Department of Pharmacy, Xianju People’s Hospital, Xianju, Zhejiang, 2Department of Pharmaceutics, Key Laboratory of Smart Drug Delivery, Ministry of Education and PLA, School of Pharmacy, Fudan University, Shanghai, 3Chongyang Center for Disease Control and Prevention, Xianning, Hubei, 4School of Life Science, Fudan University, Shanghai, People’s Republic of China Abstract: The blood–brain barrier is a formidable obstacle for glioma chemotherapy due to its compact structure and drug efflux ability. In this study, a dual-targeting drug delivery system involving Angiopep-2-conjugated biodegradable polymersomes loaded with doxorubicin (Ang-PS-DOX) was developed to exploit transport by the low-density lipoprotein receptor-related protein 1 (LRP1), which is overexpressed in both blood–brain barrier and glioma cells. The polymersomes (PS) were prepared using a thin-film hydration method. The PS were loaded with doxorubicin using the pH gradient method (Ang-PS-DOX). The resulting PS were uniformly spherical, with diameters of ~135 nm and with ~159.9 Angiopep-2 molecules on the surface of each PS. The drug-loading capacity and the encapsulation efficiency for doxorubicin were 7.94%±0.17% and 95.0%±1.6%, respectively. Permeability tests demonstrated that the proton diffusion coefficient across the PS membrane was far slower than that across the liposome membrane, and the common logarithm value was linearly dependent on the dioxane content in the external phase. Compared with PS-DOX, Ang-PS-DOX demonstrated significantly higher cellular uptake and stronger cytotoxicity in C6 cells. In vivo pharmacokinetics and brain distribution experiments revealed that Ang-PS-DOX achieved a more extensive distribution and more abundant accumulation in glioma cells than PS-DOX. Moreover, the survival time of glioma-bearing rats treated with Ang-PS-DOX was significantly prolonged compared with those treated with PS-DOX or a solution of free doxorubicin. These results suggested that Ang-PS-DOX can target glioma cells and enhance chemotherapeutic efficacy. Keywords: Angiopep-2, dual targeting, biodegradable polymersomes, doxorubicin, glioma treatmentLu FPang ZZhao JJin KLi HPang QZhang LPang ZDove Medical PressarticleAngiopep-2dual targetingbiodegradable polymersomesdoxorubicinglioma treatmentMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 12, Pp 2117-2127 (2017)
institution DOAJ
collection DOAJ
language EN
topic Angiopep-2
dual targeting
biodegradable polymersomes
doxorubicin
glioma treatment
Medicine (General)
R5-920
spellingShingle Angiopep-2
dual targeting
biodegradable polymersomes
doxorubicin
glioma treatment
Medicine (General)
R5-920
Lu F
Pang Z
Zhao J
Jin K
Li H
Pang Q
Zhang L
Pang Z
Angiopep-2-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) polymersomes for dual-targeting drug delivery to glioma in rats
description Fei Lu,1,2 Zhiyong Pang,2,3 Jingjing Zhao,2 Kai Jin,4 Haichun Li,2 Qiang Pang,2 Long Zhang,2 Zhiqing Pang2 1Department of Pharmacy, Xianju People’s Hospital, Xianju, Zhejiang, 2Department of Pharmaceutics, Key Laboratory of Smart Drug Delivery, Ministry of Education and PLA, School of Pharmacy, Fudan University, Shanghai, 3Chongyang Center for Disease Control and Prevention, Xianning, Hubei, 4School of Life Science, Fudan University, Shanghai, People’s Republic of China Abstract: The blood–brain barrier is a formidable obstacle for glioma chemotherapy due to its compact structure and drug efflux ability. In this study, a dual-targeting drug delivery system involving Angiopep-2-conjugated biodegradable polymersomes loaded with doxorubicin (Ang-PS-DOX) was developed to exploit transport by the low-density lipoprotein receptor-related protein 1 (LRP1), which is overexpressed in both blood–brain barrier and glioma cells. The polymersomes (PS) were prepared using a thin-film hydration method. The PS were loaded with doxorubicin using the pH gradient method (Ang-PS-DOX). The resulting PS were uniformly spherical, with diameters of ~135 nm and with ~159.9 Angiopep-2 molecules on the surface of each PS. The drug-loading capacity and the encapsulation efficiency for doxorubicin were 7.94%±0.17% and 95.0%±1.6%, respectively. Permeability tests demonstrated that the proton diffusion coefficient across the PS membrane was far slower than that across the liposome membrane, and the common logarithm value was linearly dependent on the dioxane content in the external phase. Compared with PS-DOX, Ang-PS-DOX demonstrated significantly higher cellular uptake and stronger cytotoxicity in C6 cells. In vivo pharmacokinetics and brain distribution experiments revealed that Ang-PS-DOX achieved a more extensive distribution and more abundant accumulation in glioma cells than PS-DOX. Moreover, the survival time of glioma-bearing rats treated with Ang-PS-DOX was significantly prolonged compared with those treated with PS-DOX or a solution of free doxorubicin. These results suggested that Ang-PS-DOX can target glioma cells and enhance chemotherapeutic efficacy. Keywords: Angiopep-2, dual targeting, biodegradable polymersomes, doxorubicin, glioma treatment
format article
author Lu F
Pang Z
Zhao J
Jin K
Li H
Pang Q
Zhang L
Pang Z
author_facet Lu F
Pang Z
Zhao J
Jin K
Li H
Pang Q
Zhang L
Pang Z
author_sort Lu F
title Angiopep-2-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) polymersomes for dual-targeting drug delivery to glioma in rats
title_short Angiopep-2-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) polymersomes for dual-targeting drug delivery to glioma in rats
title_full Angiopep-2-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) polymersomes for dual-targeting drug delivery to glioma in rats
title_fullStr Angiopep-2-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) polymersomes for dual-targeting drug delivery to glioma in rats
title_full_unstemmed Angiopep-2-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) polymersomes for dual-targeting drug delivery to glioma in rats
title_sort angiopep-2-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) polymersomes for dual-targeting drug delivery to glioma in rats
publisher Dove Medical Press
publishDate 2017
url https://doaj.org/article/014376443db64db6a24101d330ab6563
work_keys_str_mv AT luf angiopep2conjugatedpolyethyleneglycolcopolyepsiloncaprolactonepolymersomesfordualtargetingdrugdeliverytogliomainrats
AT pangz angiopep2conjugatedpolyethyleneglycolcopolyepsiloncaprolactonepolymersomesfordualtargetingdrugdeliverytogliomainrats
AT zhaoj angiopep2conjugatedpolyethyleneglycolcopolyepsiloncaprolactonepolymersomesfordualtargetingdrugdeliverytogliomainrats
AT jink angiopep2conjugatedpolyethyleneglycolcopolyepsiloncaprolactonepolymersomesfordualtargetingdrugdeliverytogliomainrats
AT lih angiopep2conjugatedpolyethyleneglycolcopolyepsiloncaprolactonepolymersomesfordualtargetingdrugdeliverytogliomainrats
AT pangq angiopep2conjugatedpolyethyleneglycolcopolyepsiloncaprolactonepolymersomesfordualtargetingdrugdeliverytogliomainrats
AT zhangl angiopep2conjugatedpolyethyleneglycolcopolyepsiloncaprolactonepolymersomesfordualtargetingdrugdeliverytogliomainrats
AT pangz angiopep2conjugatedpolyethyleneglycolcopolyepsiloncaprolactonepolymersomesfordualtargetingdrugdeliverytogliomainrats
_version_ 1718399317873524736